A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia

NCT01982071 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

59

Enrollment

INDUSTRY

Sponsor class

Stopped Due to administrative reasons

Conditions

Candidemia
Candidiasis

Interventions

DRUG: Micafungin

Sponsor

Astellas Pharma China, Inc.